Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Larson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
AIDS Research and Human Retroviruses|September 18, 2024
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected ParticipantsDirk Schürmann, Andreas Hüser, Frieder Pfäfflin, et al.
Journal of Clinical Pharmacology|April 25, 2008
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjectsJules I Schwartz, Aimee L Dallob, Patrick J Larson, et al.
Journal of Clinical Pharmacology|October 1, 2003
Pharmacokinetics of etoricoxib in patients with hepatic impairmentNancy G B Agrawal, Mark J Rose, Catherine Z Matthews, et al.
British Journal of Clinical Pharmacology|February 3, 2011
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese malesGary A Herman, Goutam C Mistry, Bingming Yi, et al.
Endocrinology|February 28, 2002
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitizationTerry P Combs, John A Wagner, Joel Berger, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
AIDS Research and Human Retroviruses|September 18, 2024
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected ParticipantsDirk Schürmann, Andreas Hüser, Frieder Pfäfflin, et al.
Journal of Clinical Pharmacology|April 25, 2008
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjectsJules I Schwartz, Aimee L Dallob, Patrick J Larson, et al.
Journal of Clinical Pharmacology|October 1, 2003
Pharmacokinetics of etoricoxib in patients with hepatic impairmentNancy G B Agrawal, Mark J Rose, Catherine Z Matthews, et al.
British Journal of Clinical Pharmacology|February 3, 2011
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese malesGary A Herman, Goutam C Mistry, Bingming Yi, et al.
Endocrinology|February 28, 2002
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitizationTerry P Combs, John A Wagner, Joel Berger, et al.
Pageof 2